2ND CANADIAN MUSCULOSKELETAL CONFERENCE FACULTY

dr-julia-alleyne

Dr. Julia Alleyne

Dr. Julia Alleyne is a Family Physician practising Sport and Exercise Medicine at the Toronto Rehabilitation Institute, University Health Network. In addition, she trained as a physiotherapist and maintained an active license for 30 years.

View Bio

Bio

Dr. Julia Alleyne is a Family Physician practising Sport and Exercise Medicine at the Toronto Rehabilitation Institute, University Health Network. In addition, she trained as a physiotherapist and maintained an active license for 30 years.  She is appointed at the University of Toronto, Department of Family and Community Medicine as an associate clinical professor.

Her work in Back Care includes lead clinician for the Core Back Tool and the Core Neck Tool. She has developed educational curriculum for primary care providers for MSK initiatives in Ontario, British Columbia and Alberta. Dr. Alleyne co-chaired the Ontario QBP in Shared Care for Low Back pain and is currently working with Health Quality Ontario to develop clinical standards for spine care.

dr-tom-appleton

Dr. Tom Appleton

Dr. Appleton is Assistant Professor of Rheumatology and Clinician Scientist in the Department of Medicine and Department of Physiology and Pharmacology at Western University in London, Canada. He is the director of the clinical and translational biology research program focused on inflammatory mechanisms and clinical phenotypes of knee and hand osteoarthritis.

View Bio

Bio

Dr. Appleton is Assistant Professor of Rheumatology and Clinician Scientist in the Department of Medicine and Department of Physiology and Pharmacology at Western University in London, Canada. He is the director of the clinical and translational biology research program focused on inflammatory mechanisms and clinical phenotypes of knee and hand osteoarthritis. Dr. Appleton’s primary research interest is the role of synovial macrophages in the development and progression of osteoarthritis, and the interplay between the synovium and articular cartilage. His multi-pillar research program also involves clinical trials of therapy in osteoarthritis, clinical studies in longitudinal patient cohorts, and musculoskeletal ultrasound. At Western, Dr. Appleton is a member of the transdisciplinary Bone and Joint Institute and a program mentor in the Collaborative Training Program in Musculoskeletal Health Research. He is also a Board Member of the Ontario Rheumatology Association and Chair of the Scientific Planning Committee for the Canadian Rheumatology Association. Dr. Appleton also has an interest in real-world evidence and the use of real world data for health quality improvement as the Informatics Committee Lead, Data Governance for the Ontario Rheumatology Association.

lauren-beaupre-square

Dr. Lauren Beaupre

Dr. Lauren Beaupre is a professor of Physical Therapy and the David Magee Endowed Chair in Musculoskeletal Research at the University of Alberta.  She is also the National Director for Hip Fracture for Bone and Joint Canada.

View Bio

Bio

Lauren Beaupre is a professor of Physical Therapy and the David Magee Endowed Chair in Musculoskeletal Research at the University of Alberta.  She is also the National Director for Hip Fracture for Bone and Joint Canada. Her research interests focus on recovery of patients who undergo orthopaedic surgery, with a particular focus on hip fracture and total joint arthroplasty as well as knowledge translation and implementation science to move best evidence into clinical practice.

dr-jacques-brown

Dr. Jacques Brown

Jacques P. Brown is a rheumatologist and Canadian authority in metabolic bone diseases. He is a clinical professor at the Faculty of Medicine, Université Laval and a clinical researcher at the CHU de Québec Research Centre – Université Laval.

View Bio

Bio

Jacques P. Brown is a rheumatologist and Canadian authority in metabolic bone diseases. He is a clinical professor at the Faculty of Medicine, Université Laval and a clinical researcher at the CHU de Québec Research Centre – Université Laval. He is a Director for the Canadian Multicentre Osteoporosis Study and the Principal Investigator of the Recognizing Osteoporosis and its Consequences in Quebec Programme. Dr. Brown twice received the John B Johnson Award from The Paget Foundation for his outstanding contribution to Paget’s disease of bone research and was awarded the Lindy Fraser Memorial Award from Osteoporosis Canada for his leadership and dedication to the “2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada”.

In 2009, he was decorated as a Knight of the Ordre national du Québec, the highest distinction awarded by the Quebec government. In 2017, he was awarded the Canadian Rheumatology Association’s Distinguished Investigator Award for his exceptional contribution to rheumatology in Canada.”

dr-peggy-cawthon

Dr. Peggy Cawthon

Dr. Cawthon is currently Senior Scientist at California Pacific Medical Center Research Institute and Associate Adjunct Professor at UCSF. Dr. Cawthon’s current research interests include maintenance of mobility in old age; sarcopenia (age-related muscle loss); frailty; the decline of physical function with age; and osteoporosis, particularly in older men.

dr-angela-cheung

Dr. Angela Cheung

Dr. Angela Cheung is the Founding Director of University Health Network Osteoporosis Program, the Founding Director of Centre of Excellence in Skeletal Health Assessment (CESHA), a Senior Scientist at Toronto General Research Institute, and Professor of Medicine at the University of Toronto. She is currently holding a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health.

View Bio

Bio

Dr. Angela Cheung is the Founding Director of University Health Network Osteoporosis Program, the Founding Director of Centre of Excellence in Skeletal Health Assessment (CESHA), a Senior Scientist at Toronto General Research Institute, and Professor of Medicine at the University of Toronto. She is currently holding a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health.  She is the past chair for Osteoporosis Canada Scientific Advisory Council, and an elected member of the International Osteoporosis Foundation Council of Scientific Advisors.  She obtained her M.D. degree from Johns Hopkins University School of Medicine in 1988, and her Ph.D. degree from Harvard University in 1997. She has been in clinical practice for more than 25 years, and specializes in osteoporosis and postmenopausal health.  She has received many honors and awards throughout her medical career for her excellence in clinical work, research and education, including the CIHR mid-career and senior scientist awards, the Canadian Society of Internal Medicine Dr. David Sackett Senior Investigator Award, the Osteoporosis Canada Lindy Fraser Memorial Award, the Ontario Premier’s Research Excellence Award, Ontario Ministry of Health and Long Term Care Health Services Research Scientist Award, University of Toronto Eudenie Stuart Award for best mentorship, and UHN Department of Medicine Award for Excellence in Clinical Teaching.  She has been a member of the International Society of Clinical Densitometry (ISCD) since 1998 and has served on the Publication Committee.  She is the current chair of the Canadian ISCD Panel.

dr-laura-cruz

Dr. Laura Cruz

Dr. Laura Cruz has a background in Family Medicine and has practiced sport and exercise medicine since 1996.  Her career interests include medical education and injury prevention. She is a Lecturer in the Department of Family and Community Medicine University of Toronto.

View Bio

Bio

Dr. Laura Cruz has a background in Family Medicine and has practiced sport and exercise medicine since 1996.  Her career interests include medical education and injury prevention. She is a Lecturer in the Department of Family and Community Medicine University of Toronto, and the Assistant Programme Director for the Dept of Family and Community Medicine Enhanced Skills PGY3 in Sport and Exercise Medicine

Dr Cruz has been the League Physician for the Canadian Women’s Hockey League since its inception and a physician with Skate Canada since 1996.

Her Sport Medicine expertise includes concussion management, injury prevention in youth/ varsity sport, and osteoarthritis management. Her practice includes patients of all ages and skill levels from developmental athletes to Olympians.

Currently Dr Cruz is the Medical Director of LiveActive Sport Medicine Health and Performance and a member of the York University York Lions Sports Medicine Team. She is the immediate Past President of the Canadian Academy of Sport and Exercise Medicine.

dr-aileen-davis

Dr. Aileen Davis BScPT MSc PhD

Aileen Davis BScPT MSc PhD trained as a physiotherapist and clinical epidemiologist, receiving her undergraduate physiotherapy degree and doctorate from the University of Toronto. She is Division Head and a Senior Scientist in the Division of Health Care and Outcomes Research, Krembil Research Institute, University Health Network, Toronto, Canada.

View Bio

Bio

Aileen Davis BScPT MSc PhD trained as a physiotherapist and clinical epidemiologist, receiving her undergraduate physiotherapy degree and doctorate from the University of Toronto. She is Division Head and a Senior Scientist in the Division of Health Care and Outcomes Research, Krembil Research Institute, University Health Network, Toronto, Canada . She is a Professor at the University of Toronto in the Departments of Physical Therapy and Surgery and holds Full Membership in the School of Graduate Studies (University of Toronto) in the Institute of Health Policy, Management and Evaluation, Rehabilitation Science Institute and the Institute of Medical Science. She is currently the Co-Chair of Bone and Joint Canada and Director of their Osteoarthritis Initiatives and a member of the Board of the Osteoarthritis Research Society International (OARSI). She is an Associate Editor for Osteoarthritis and Cartilage and on the Editorial Board of Arthritis Care & Research.

Aileen’s research focuses on evaluation of outcome in musculoskeletal conditions including osteoarthritis, joint replacement and musculoskeletal oncology with an emphasis on evaluation of modifiable predictors of outcome. She has developed of physical function for both lower and upper extremity conditions including application of item response theory approaches. Current work includes national implementation and evaluation of an education and exercise program for people with hip and knee osteoarthritis.

michael-dunbar-md-phd

Dr. Michael Dunbar, MD FRCSC PHD

Michael Dunbar is an orthopaedic surgeon trained at Dalhousie University with subspecialty training in arthroplasty from the University of Western Ontario.  He completed a PhD in Lund Sweden as a member of the Swedish Knee Arthroplasty Registry, concentrating on subjective outcomes after knee replacement surgery.  He is co-chair, Canadian Joint Replacement Registry; Research Chair, The Knee Society; Director of Research and President-Elect, Canadian Arthroplasty Society.

View Bio

Bio

Michael Dunbar is an orthopaedic surgeon trained at Dalhousie University with subspecialty training in arthroplasty from the University of Western Ontario.  He completed a PhD in Lund Sweden as a member of the Swedish Knee Arthroplasty Registry, concentrating on subjective outcomes after knee replacement surgery.  He is co-chair, Canadian Joint Replacement Registry; Research Chair, The Knee Society; Director of Research and President-Elect, Canadian Arthroplasty Society.  His credits include 2010 J. Edouard Samson Award for Outstanding Canadian Orthopaedic Researcher over a 5-Year Period, named as one of the “Top 22 North American Knee Surgeons” by his peers and one of “10 Orthopedic Surgeon Tech Entrepreneurs to Know” by Becker’s Spine Review.  In 2015 he was awarded the inaugural QEII Endowed Chair of Arthroplasty Outcomes at Dalhousie University with the overarching mandate of improving arthroplasty care and outcomes in Nova Scotia.  His most recent accolade was his induction as a fellow of the Canadian Academy of Health Sciences.

Dunbar is the author of over 120 peer reviewed journal articles, 15 textbook chapters, and has delivered over 320 invited presentations in countries around the world.  To date, he has been involved as principle or co-investigator in local, national, and international grants with total capture of over $24 million dollars.

His particular interest in data analytics has used Nova Scotia health care data, and other data sets, to compile specific information about orthopaedic patient characteristics and their health outcomes.  Using complex mathematical analysis, his group has linked patient characteristics that may predict poor recovery after surgery, and most recently, correlations between transfusions and infection rates at a site-based level.

“Using big data, surgical robotics and mobile technology, provides a real opportunity to rethink the delivery surgical care in our Province”, says Dunbar.  These steps towards “customized” health care improve our ability to deliver better treatment.  In particular, the use of large administrative datasets can enable the system as a whole to reduce post-surgery complications and re-admissions, paving the way to improving the health of Nova Scotians overall.

dr-john-flannery

Dr. John Flannery

Dr. John Flannery is a Physiatry graduate from Queen’s University and Medical Director of Toronto Rehab’s Musculoskeletal and Multisystem Rehabilitation Program, University Health Network.  His wide range of expertise focuses mainly on complex rehabilitation (amputee, SCI, ABI, burn, polytrauma and peripheral nerve injury) with particular focus in complex musculoskeletal disease and chronic pain during the past 16 years.

View Bio

Bio

Dr. John Flannery is a Physiatry graduate from Queen’s University and Medical Director of Toronto Rehab’s Musculoskeletal and Multisystem Rehabilitation Program, University Health Network.  His wide range of expertise focuses mainly on complex rehabilitation (amputee, SCI, ABI, burn, polytrauma and peripheral nerve injury) with particular focus in complex musculoskeletal disease and chronic pain during the past 16 years.

Dr. Flannery is Co-Director of the Comprehensive Integrated Pain Program at University Health Network, as well the Operations Committee Lead and Executive Committee Member of Project ECHO – Ontario Pain Program, which is a new initiative in Canada, funded by Ontario Ministry of Health, to help chronic pain patients across Ontario.  He is Co-Chair of the University of Toronto Centre for the Study of Pain Education Sub-Committee and sits on numerous other committees, including the Toronto Academic Pain Medicine Institute (TAPMI) and the Committee for Provincial Low Back Pain: Inter-professional Spine Assessment and Education Centres.

He completed the Master Teacher Program through the University of Toronto, Department of Medicine in 2005.  In May 2012 he received certificates as a trainer in Crucial Conversations and Difficult Conversations.

Academically, Dr. Flannery is a clinician-educator at the rank of Associate Professor in the Division of Physical Medicine and Rehabilitation, Department of Medicine at University of Toronto.

dr-andrea-furlan

Dr. Andrea Furlan

Dr. Andrea Furlan is an Associate Professor in the Department of Medicine at the University of Toronto and staff physician and scientist at the Toronto Rehabilitation Institute. She is also Associate Scientist at the Institute for Work & Health in Toronto.

View Bio

Bio

Dr. Andrea Furlan is an Associate Professor in the Department of Medicine at the University of Toronto and staff physician and scientist at the Toronto Rehabilitation Institute. She is also Associate Scientist at the Institute for Work & Health in Toronto. She completed a PhD in Clinical Epidemiology from the Department of HPME of the University of Toronto and has extensive experience in reviewing the scientific literature for the Cochrane Collaboration and for clinical practice guidelines. She received a CIHR New Investigator Award and her research focus is on treatments of chronic pain including medications, complementary and alternative therapies, and rehabilitation. She was the team leader for the development of the Canadian Opioid Guideline, and is now involved with Guideline’s National Faculty in dissemination and implementation of the guideline across Canada. She developed the Opioid Manager, a point-of-care tool for physicians using opioids for chronic pain, which is available in many EMR platforms and as an App for iPad/iPhone. Dr. Furlan is a co-Chair of Echo Ontario for Pain and Opioid Stewardship.

dr-claudia-gagnon

Dr. Claudia Gagnon

Dr. Claudia Gagnon is an Assistant Professor in the Department of Medicine at Université Laval and a clinician-researcher scholar of the Fonds de recherche en santé du Québec working at the CHU de Québec Research Centre. She practices as an adult endocrinologist at CHU de Québec.

View Bio

Bio

Dr. Claudia Gagnon is an Assistant Professor in the Department of Medicine at Université Laval and a clinician-researcher scholar of the Fonds de recherche en santé du Québec working at the CHU de Québec Research Centre. She practices as an adult endocrinologist at CHU de Québec. After completing residency training in adult endocrinology at Université de Sherbrooke in 2006, she undertook a 3-year fellowship in metabolic bone diseases and phosphocalcic metabolism in Melbourne, Australia. Her research focuses on the effects of obesity, type 2 diabetes and their treatments on bone health. She receives funding from Diabetes Canada, Diabète Québec and the Canadian Institutes of Health Research.

dr-lora-giangregorio

Dr. Lora Giangregorio

Dr. Lora Giangregorio is an Associate Professor in the Department of Kinesiology at the University of Waterloo, and an affiliated scientist with University Health Network, the Geriatric Education and Research in Aging Sciences Centre, and the Schlegel-UW Research Institute for Aging.

View Bio

Bio

Dr. Lora Giangregorio is an Associate Professor in the Department of Kinesiology at the University of Waterloo, and an affiliated scientist with University Health Network, the Geriatric Education and Research in Aging Sciences Centre, and the Schlegel-UW Research Institute for Aging. She leads the Bone Health and Exercise Science Laboratory (BonES lab), and her research aims to reduce the burden of osteoporotic fractures, with a focus on safe and effective physical activity.  Lora is the Schlegel Research Chair in Mobility and Aging. She is also a member of the Scientific Advisory Council for Osteoporosis Canada, and she contributed to the development of Osteoporosis Canada’s Bone FitTM exercise training program.

dr-cheryl-rockman-greenberg

Dr. Cheryl Rockman-Greenberg

Dr. Cheryl Rockman- Greenberg obtained her medical degree from McGill University in Montreal in 1974. At McGill, her mentors introduced her to the emerging fields of Medical and Biochemical Genetics. She knew then that, if provided with the opportunity, she would pursue an academic medical career, working to identify the cause of rare and ultrarare genetic disorders and to help ease their burden on patients and their families.

View Bio

Bio

Dr. Cheryl Rockman- Greenberg obtained her medical degree from McGill University in Montreal in 1974. At McGill, her mentors introduced her to the emerging fields of Medical and Biochemical Genetics. She knew then that, if provided with the opportunity, she would pursue an academic medical career, working to identify the cause of rare and ultrarare genetic disorders and to help ease their burden on patients and their families. She subsequent trained in Pediatrics and Medical Genetics and she became a Fellow of the Royal College of Physicians and Surgeons of Canada in Pediatrics in 1979 and in Medical Genetics in 1992 and a Fellow of the Canadian College of Medical Geneticists in 1982. Her academic career as a clinical and metabolic geneticist – her “first job”- began at Winnipeg Children’s Hospital and the Department of Pediatrics and Child Health, University of Manitoba in 1979 where she has worked ever since. Over her career, Dr. Rockman- Greenberg served as Director of the Metabolic Service in the Program of Genetics and Metabolism, Winnipeg Regional Health Authority (WRHA) and from 2004 to 2014 she was Medical Director of the Child Health program, WRHA and Head of the Department of Pediatrics and Child Health, University of Manitoba. She currently is a clinician scientist in the Children’s Hospital Research Institute of Manitoba and has developed the Metabolic Disorders Clinical Trials Research team. Her research has focused on the identification of the molecular basis for genetic disorders that are over-represented in Manitoba’s unique populations.  Subsequently, in direct collaboration with community leaders, she and her colleagues have translated research discoveries into relevant patient care programs including the development of new diagnostic tests, expanded newborn screening programs and carrier testing initiatives.  Most recently she has been the principal investigator for Canada of an industry- sponsored clinical trial of a new enzyme replacement therapy (ERT) drug for the treatment of the rare metabolic bone disorder called hypophosphatasia (HPP).  ERT has dramatically changed the natural history of the most severe forms of HPP from previously untreatable into treatable disorders. Over the course of her esteemed career, Dr. Rockman-Greenberg has received numerous awards including being named to the 2012 list of Canada’s Most Powerful Women: Top 100, in the Trailblazers and Trendsetters category, being inducted into Canadian Academy of Health Sciences in 2014 and receiving the Health Research Foundation Innovations Medicine Canada Medal of Honour in 2016.  In April of 2018 she will be inducted into the Canadian Medical Hall of Fame. She is the currently a clinical geneticist in the Program of Genetics and Metabolism, WRHA, a clinician scientist in the Children’s Hospital Research Institute of Manitoba and a Distinguished Professor in the Departments of Pediatrics and Child Health and Biochemistry and Medical Genetics, University of Manitoba.

dr-david-goltzman

Dr. David Goltzman

David Goltzman is Professor of Medicine and  Physiology at McGill University and Senior Physician in the Endocrine Division  of the McGill University Health Centre. He has advanced our knowledge of parathyroid hormone(PTH), PTH related peptide and vitamin D, and had major impact on our understanding metabolic bone diseases.

View Bio

Bio

David Goltzman is Professor of Medicine and  Physiology at McGill University and Senior Physician in the Endocrine Division  of the McGill University Health Centre. He has advanced our knowledge of parathyroid hormone(PTH), PTH related peptide and vitamin D, and had major impact on our understanding metabolic bone diseases. He is also principal investigator of the Canadian Multicentre Osteoporosis Study(CaMos), a longitudinal cohort study of osteoporosis. Dr Goltzman has  received the Aurbach Award of the US Endocrine Society, the Raisz Award of the American Society for Bone and Mineral Research(ASBMR), fellowship in the Royal Society of Canada and in the Canadian Academy of Health Sciences, the Order of Canada, an honorary professorship from Nanjing University and the degree of Doctor Honoris Causa from the University of Athens. He is a past President of the ASBMR, the Canadian Society of Clinical Investigation and the Canadian Society of Endocrinology and Metabolism.

dr-gillian-hawker

Dr. Gillian Hawker

Dr. Hawker is the Sir John and Lady Eaton Professor and Chair of the Department of medicine at the University of Toronto and a Senior Scientist at the Women’s College research Institute. She is a health services researcher who has published over 240 peer-reviewed articles; her main research focus is on disparities in access to care for people living with osteoarthiritis.

dr-famida-jiwa

Dr. Famida Jiwa

Dr. Famida Jiwa is the President and CEO of Osteoporosis Canada, and has been with the organization since 2006. Prior to joining Osteoporosis Canada, Dr. Jiwa was the former Provincial Osteoporosis Co-ordinator, employed by the Ontario Ministry of Health and Long Term Care and charged with rolling out all aspects of the $5 million annual Ontario Osteoporosis Strategy.

View Bio

Bio

Dr. Famida Jiwa is the President and CEO of Osteoporosis Canada, and has been with the organization since 2006. Prior to joining Osteoporosis Canada, Dr. Jiwa was the former Provincial Osteoporosis Co-ordinator, employed by the Ontario Ministry of Health and Long Term Care and charged with rolling out all aspects of the $5 million annual Ontario Osteoporosis Strategy. Prior to this and after leaving her private practice in Orlando, Florida, Dr. Jiwa was a Program Consultant for the Acute Services Division of the Ministry of Health, where she played a significant role in project planning, implementation and evaluation of a number of provincial health initiatives, including chronic kidney disease, asthma and age-related macular degeneration. In 2014, Dr. Jiwa was re-elected chair of the Patient Societies Subcommittee of the Committee of National Societies (CNS) of the International Osteoporosis Foundation (IOF) for for a 4th term of two years. Activities of these societies include lobbying for better prevention, promoting early diagnosis for those at high risk for osteoporosis and empowering the patient through support groups and independent information about treatment options.

She holds a Masters Degree in Health Administration from the Department of Health Policy, Management and Evaluation from the University of Toronto, a Doctorate of Chiropractic from the Canadian Memorial Chiropractic College in Toronto, as well as an Honours Bachelor of Science, Genetics and Psychology from the University of Toronto.  She was the recipient of the 2006 Robert Duff Baron Scholarship for academic excellence and leadership in public and community health.  Dr. Jiwa has also attained the designation of Certified Health Executive from the Canadian College of Health Service Executives.

dr-rg-josse

Dr. R.G. Josse

Dr. R.G. Josse graduated in Medicine with Honours from the University of London.  He undertook Postgraduate Training at various Teaching Hospitals at the University of London and then came to Canada and completed his Endocrine Clinical Training, after which he did a Research Fellowship at the University of Toronto followed by a further Clinical Fellowship at the Massachusetts General Hospital in Boston.

View Bio

Bio

Dr. R. Josse graduated in Medicine with Honours from the University of London.  He undertook Postgraduate Training at various Teaching Hospitals at the University of London and then came to Canada and completed his Endocrine Clinical Training, after which he did a Research Fellowship at the University of Toronto followed by a further Clinical Fellowship at the Massachusetts General Hospital in Boston.  He holds Fellowships in Internal Medicine from the American College of Physicians, Royal College of Physicians of London and Internal Medicine and Endocrinology Fellowships from the Royal College of Physicians of Canada.He is also a fellow of the American College of Endocrinology

He is a Full Professor in the Departments of Medicine and Nutritional Sciences at the University of Toronto. He is also an adjunct scientist in the Li Ka Shing knowledge translation institute at St Michael’s Hospital ( SMH). He is the past head of the Division of Endocrinology and Metabolism  and  has  completed a  term as Associate Physician-in-Chief at SMH. He is the director of the Metabolic Bone Disease and Osteoporosis Centre at SMH.He is an associate staff physician at UHN( Toronto General hospital) in the division of endocrinology and metabolism.He was the Toronto Director of the Canadian Multicentre Osteoporosis Study( CaMos).  He is a consultant to ( and a past Chair of ) the Scientific Advisory Council of the Osteoporosis Society of Canada ( now Osteoporosis Canada) .He is a member of the committee of scientific advisors of the International Osteoporosis Foundation( IOF ).  He is a past President of the Canadian Society of Endocrinology and Metabolism (CSEM) and was the inaugural   chair of  the CHE development and  e-CME committee of the CSEM. He received  the 2007 Distinguished Service Award of the CSEM..He has also received the 2007 Distinction  in Clinical Endocrinology award of the American College of Endocrinology. He is a past recipient of the Lindsay Fraser award of Osteoporosis Canada.He received the  2012 Queen Elizabeth 11 Diamond Jubilee award medal .He received the clinician educator award of CSEM in 2015

His major research interests include calcium metabolism and osteoporosis as well as diabetes, and various nutritional metabolic problems.  He has published/co-authored over  three hundred articles in peer reviewed journals and twenty-one book chapters.  He lectures widely both nationally and internationally on various endocrine and metabolic topics.

dr-david-kendler

Dr. David Kendler

Dr. David L Kendler graduated from the MD program at the University of Toronto in 1977.  After completing a rotating internship in Toronto, he practiced for several years in Canada, Botswana, and New Zealand.

View Bio

Bio

Dr. David L Kendler graduated from the MD program at the University of Toronto in 1977.  After completing a rotating internship in Toronto, he practiced for several years in Canada, Botswana, and New Zealand.  He returned to Internal Medicine training in 1983 in Christchurch, New Zealand and in 1984 joined the Internal Medicine program in Halifax, Canada.  In 1985 he moved to Vancouver to complete Internal Medicine and Endocrinology training at the University of British Columbia.  After a 2-year thyroid immunology Fellowship in New York, he returned to the University of British Columbia Faculty of Medicine where he is now a Professor of Medicine in Endocrinology.  He has led osteoporosis programs at Children and Women’s Hospital and St. Paul’s Hospital.  He is the director of Prohealth Clinical Research, a major North American centre for clinical trials in the area of osteoporosis.  He serves on the Scientific Advisory Council of Osteoporosis Canada and Chairs the Western Osteoporosis Alliance.  He is a Past-President of the International Society for Clinical Densitometry.  He is a member of the Committee of Scientific Advisors of the International Osteoporosis Foundation and is co-Chair of the Western Osteoporosis Alliance.  He has been awarded the John Bilezekian ISCD Global Leadership Award. He has served on the Board of Directors of the Canadian Menopause Society. He has published over 120 peer-reviewed papers on osteoporosis therapies, osteoporosis risk assessment, and autoimmune thyroid disease.

dr-carol-kennedy

Carol Kennedy

Carol Kennedy has a clinical background in physiotherapy combined with training in clinical epidemiology. She is a Lead in the Quality Standards program at Health Quality Ontario (HQO) working on the Osteoarthritis Quality Standard.

dr-karim-khan

Dr. Karim Khan

Dr. Karim Khan (MD, PhD, MBA) is the Scientific Director of CIHR’s Institute of Musculoskeletal Health and Arthritis (IMHA) and a professor and clinician-scientist in the Department of Family Practice and School of Kinesiology at the University of British Columbia (UBC), where he has taught since 2000.

View Bio

Bio

Dr. Karim Khan (MD, PhD, MBA) is the Scientific Director of CIHR’s Institute of Musculoskeletal Health and Arthritis (IMHA) and a professor and clinician-scientist in the Department of Family Practice and School of Kinesiology at the University of British Columbia (UBC), where he has taught since 2000.

Dr. Khan is internationally recognised for studies promoting greater mobility among vulnerable seniors, and is a respected leader in the field of tendon injuries, osteoporosis, fall prevention and exercise promotion for health. He published over 300 peer-reviewed publications and has been the primary supervisor for 11 PhD trainees in the clinical and health service research domains.

Since 2008, Professor Khan has been Editor-in-Chief of the prominent and highly influential British Journal of Sports Medicine (BJSM). He is also the co-author of the best-selling textbook Brukner & Khan’s Clinical Sports Medicine, now in its 5th edition.

Dr. Khan is passionate about knowledge translation and patient engagement, and was responsible for establishing the BJSM’s social media accounts, podcast and blog that have reached millions of viewers and listeners.

dr-william-leslie

Dr. William Leslie

Dr. William Leslie is Professor of Medicine and Radiology at the University of Manitoba with over 350 peer-reviewed publications.  His research interests are in fracture risk assessment and osteoporosis testing.  He is Past President of the International Society for Clinical Densitometry, Past Chair of the Osteoporosis Canada Scientific Advisory Council, co-led the “2010 Clinical Practice Guidelines in Osteoporosis”, and Director of the Manitoba Bone Density Program.

jay-magaziner-phd

Dr. Jay Magaziner, Ph.D., M.S.Hyg

Jay Magaziner received his doctoral degree in 1980 from the Committee on Human Development at the University of Chicago, where he was a trainee in adult development and aging.  In 1982, he received an M.S.Hyg. in epidemiology from the University of Pittsburgh Graduate School of Public Health.

View Bio

Bio

Jay Magaziner received his doctoral degree in 1980 from the Committee on Human Development at the University of Chicago, where he was a trainee in adult development and aging.  In 1982, he received an M.S.Hyg. in epidemiology from the University of Pittsburgh Graduate School of Public Health.

Jay Magaziner, Ph.D., M.S.Hyg is Professor and Chair, Department of Epidemiology and Public Health, University of Maryland (UM) School of Medicine and Director, UM Center for Research on Aging. He pursues research on hip fracture recovery, psychosocial aspects of health, and methods of studying older populations. The major focus of his work is to identify ways of enhancing functioning and improving the quality of life for older persons.  He founded the Baltimore Hip Studies, has been continuously funded by the National Institute on Aging (NIA) since 1983, and has received two consecutive MERIT Awards from the NIA in recognition of his contributions and innovative research on hip fracture recovery. His recent work has concentrated on functional and physiological consequences of hip fracture and on developing and testing multi-modal strategies for maximizing recovery.  He has published more than 225 manuscripts, served on international panels of scientists and clinicians addressing outcomes from hip fracture and NIH review panels, and mentored over 35 pre- and post-doctoral trainees and junior faculty. Currently, he is principal investigator of an NIA sponsored P30 Older Amercans Independence Center,  an NIA-supported phase III trial of a home based multi-modall program to improve walking ability in older hip fracture patients, an R37 studying mechanisms underlying improvement in walking ability after hip fracture. He also leads an NIA-supported T32 pre- and post-doctoral training program in the epidemiology of aging.

dr-laetitia-michou

Dr. Laetitia Michou

Dr. Michou has completed her medicine studies at the University of Angers (France) in 1998, her Rheumatology residency at the Denis Diderot-Paris VII University (France) in 2005 and her PhD in Human Genetics at the René Descartes-Paris V University (France) in 2007.

View Bio

Bio

Dr. Michou has completed her medicine studies at the University of Angers (France) in 1998, her Rheumatology residency at the Denis Diderot-Paris VII University (France) in 2005 and her PhD in Human Genetics at the René Descartes-Paris V University (France) in 2007. She had in parallel completed a clinical fellowship of two years (2005-2007) in fragility bone diseases at the centre Viggo Petersen, Rheumatology department, Lariboisière hospital, Assistance publique-Hôpitaux de Paris, France.

Dr Michou is a clinical investigator at the Centre de Recherche du CHU de  Québec and rheumatologist at the CHU de Québec since November 2007, and associate professor at the Department of Medicine of the Laval University, Quebec. Dr Michou is the principal investigator of several academic research projects in the field of bone diseases. She supervises master and PhD students, as well as clinical research projects of rheumatology and internal medicine residents.

She is the author or coauthor of 53 scientific refereed articles, more than 100 oral or poster communications in scientific congresses, and about 30 articles of medical continuing education for rheumatologists or family doctors. She is member of the editorial board of the Revue du rhumatisme (France), Joint Bone Spine (France) and Arthrovision (France).

Research interests of Dr. Michou are human genetics of bone and joint diseases, particularly Paget’s disease of bone, rare bone diseases, osteoporosis, and rheumatoid arthritis.

dr-suzanne-morin

Dr. Suzanne Morin

Dr. Suzanne Morin graduated from the Faculty of Medicine at Université Laval de Québec. She did her Internal Medicine specialty training and obtained a Master’s in epidemiology and biostatistics from McGill University, where she is now Associate Professor in the Department of Medicine, member of the divisions of General Internal Medicine, Endocrinology and Clinical Epidemiology and scientist at the Research Institute of the McGill University Health Center.

View Bio

Bio

Dr. Suzanne Morin graduated from the Faculty of Medicine at Université Laval de Québec. She did her Internal Medicine specialty training and obtained a Master’s in epidemiology and biostatistics from McGill University, where she is now Associate Professor in the Department of Medicine, member of the divisions of General Internal Medicine, Endocrinology and Clinical Epidemiology and scientist at the Research Institute of the McGill University Health Center. Dr Morin’s research program includes the evaluation of health-related outcomes of osteoporosis, and implementation of health system improvement programs for patients who have sustained fractures such as fracture liaison services, pain management and recovery. She also studies the epidemiology and pathogenesis of atypical femur fractures associated with long-term bisphosphonate use, and safety of calcium supplements on vascular health in postmenopausal women. She is a scholar from the Fondsde Recherche du Québec en Santé, and has received funding from the Canadian Institutes of Health Research and other peer-reviewed agencies. Since 2015, she chairs the Scientific Advisory Council of Osteoporosis Canada.

dr-robert-petrella

Dr. Robert Petrella

Dr. Robert Petrella is a Professor in the Department of Family Medicine at Western University, (London, Ontario CANADA), with cross-appointments in Kinesiology and Cardiology. Dr. Petrella is the Medical Director of the Canadian Centre for Activity and Aging and is a practising Physician with St. Joseph’s Health Care London.

View Bio

Bio

Dr. Robert Petrella is a Professor in the Department of Family Medicine at Western University, (London, Ontario CANADA), with cross-appointments in Kinesiology and Cardiology. Dr. Petrella is the Medical Director of the Canadian Centre for Activity and Aging and is a practising Physician with St. Joseph’s Health Care London. Throughout 2005-2015, Dr. Petrella was the inaugural Beryl and Richard Ivey Research Chair, as well as Program Leader for the former Aging, Rehabilitation, and Geriatric Care Program of Lawson Health Research Institute (now referred to as the Parkwood Institute Research Program).

Dr. Petrella’s research is focused on lifestyle interventions for chronic disease prevention and management. His research is dedicated to furthering multi- and inter-disciplinary research on lifestyle management, physical activity, chronic diseases, and innovative technologies to improve the lives of all Canadians, with a specific focus on vulnerable populations (i.e., men, older adults, indigenous, and those living in rural and remote regions).

Dr. Petrella’s publications cross disciplines and span topics including lifestyle prescription, healthy aging, real-world rural and remote practice, cardiovascular disease, diabetes, mobility, osteoarthritis, men’s health, and eHealth (totalling over 200 peer-reviewed articles with 8393 citations). Dr. Petrella’s research has also led to 2 patents in chronic disease therapy, 5 trademarks, and the development of 2 smartphone apps to extend research reach.

frank-rauch-md

Dr. Frank Rauch

Frank Rauch, MD, is a Professor of Pediatrics and clinician-scientist at the Shriners Hospital for Children and at McGill University. He obtained his MD degree from the Technical University of Munich, and trained as a pediatrician at the Children’s Hospital of Cologne University, Germany.

View Bio

Bio

Frank Rauch, MD, is a Professor of Pediatrics and clinician-scientist at the Shriners Hospital for Children and at McGill University. He obtained his MD degree from the Technical University of Munich, and trained as a pediatrician at the Children’s Hospital of Cologne University, Germany. His clinical activities and research program concentrate on improving bone health in children, with a special focus on genetic conditions leading to fractures and on the role of the muscle system in bone diseases. In his recent work, Dr. Rauch has identified new genetic causes of brittle bone disorders and has assessed the long-term effects of bisphosphonate treatment in children with osteogenesis imperfecta. He is also collaborating with Statistics Canada in a study that assesses muscle and bone health in Canadians. Dr. Rauch has authored or coauthored more than 200 original publications.

dr-wendy-ward

Dr. Wendy Ward

Dr. Wendy Ward is a Professor in the Faculty of Applied Health Sciences at Brock University where she holds a Canada Research Chair in Bone and Muscle Development. Wendy’s research program, funded by major government granting agencies, studies how foods and food components can set us on a better trajectory for bone health throughout the lifespan.

View Bio

Bio

Dr. Wendy Ward is a Professor in the Faculty of Applied Health Sciences at Brock University where she holds a Canada Research Chair in Bone and Muscle Development. Wendy’s research program, funded by major government granting agencies, studies how foods and food components can set us on a better trajectory for bone health throughout the lifespan. The goal of her research program is to develop dietary strategies that help protect against fragility fracture and osteoporosis. These strategies include novel foods and food components such as soy and its isoflavones; flaxseed and its omega-3 fatty acid; fish oil; and flavonoids in tea. She has published many peer-reviewed articles, invited reviews and books chapters on nutrition and women’s health issues, including herbal and nutritional supplements.  Wendy is a member of the Scientific Advisory Council of Osteoporosis Canada. She is actively involved in continuing education for health professionals and community groups on topics about nutrition and health.

dr-any-kin-on-wong

Dr. Andy Kin On Wong

Dr. Andy Kin On Wong is an Assistant Professor of Epidemiology at the Dalla Lana School of Public Health at the University of Toronto. He is also appointed as Assistant Scientist at the University Health Network  under the Joint Department of Medical Imaging and Arthritis Program.

View Bio

Bio

Dr. Andy Kin On Wong is an Assistant Professor of Epidemiology at the Dalla Lana School of Public Health at the University of Toronto. He is also appointed as Assistant Scientist at the University Health Network  under the Joint Department of Medical Imaging and Arthritis Program. He received his PhD in Medical Sciences with specialization in imaging science at McMaster University with Dr. Jonathan D. Adachi, trained in epidemiology using population-based cohort studies at UCSF with Dr. Steven Cummings, and completed his postdoctoral fellowship with Dr. Angela Cheung at the Toronto General Research Institute with training in advanced longitudinal biostatistics. Dr. Wong is a leading expert in bone, muscle, fat, and joint CT and MR imaging. He was awarded the Vanier CGS award in 2011 for his leadership in the CaMos Bone Quality Study. He has since been the director of this investigation that examined over 800 women across 6 cities to study CT-derived bone microarchitecture and muscle information and how they can predict incident fractures and falls. He is currently investigating postmenopausal women with knee osteoarthritis who have low bone mass and increased risk of fractures. Specifically, he is studying osteoporosis and micro-fractures in subchondral bone of the knee using high-resolution CT , as well as examining the role of these imaging correlates on knee symptoms in this cohort. He is also interested in the effect of more potent antiresorptive therapies on mitigating bone micro-damage and subchondral bone marrow lesions.